Breslin Research Foundation
- Assets
- $229.8k
- Revenue
- $407.3k
- Investments
- $0.0
- Employees
- 0
- Location
- Taos, NM
- Founding
- 11/2019
- Data as of
- 12/2021
- EIN
- 84-2596757
Organization Overview
Breslin Research Foundation is located in Taos, NM. The organization was established in 2019. According to its NTEE Classification (G01) the organization is classified as: Alliances & Advocacy, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Breslin Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Breslin Research Foundation generated $407.3k in total revenue. All expenses for the organization totaled $337.9k during the year ending 12/2021.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
SCIENTIFIC RESEARCH IN THE STUDY OF CANCER AND PUBLIC EDUCATION IN REGARD TO COVID-19
Describe the Organization's Program Activity:
Part 3 - Line 4a
BRESLIN FUNDED THE COMPLETION OF THE 3RD GENERATION BETA PROTOTYPE OF THE CUTTING EDGE BIOTECHNOLOGY KNOW AS SNIP ITT (SYSTEMIC NEUROMORPHIC INTELLIGENCE PROPAGATION INFORMATION TRANSFER TECHNOLODY). IN PHASE 1, TWO TEST ARTICLES WERE SUBMITTED TO THE NEW YORK MEDICAL COLLEGE FOR STUDIES ON CANCER CELL LINES. THE STUDIES WERE TESTED AND DEEMED HIGHLY SIGNIFICANT AND WORTHY OF ONGOING RESEARCH. A PHASE 2 STUDY LOOKED AT TELOMERE LENGTH AND TELOMERASE QUANTITATIVE EXPRESSION ALONG WITH MULTIPLE TUMOR SUPPRESSOR GENES. BOTH PHASES PROVIDED SIGNIFICANT VERIFICATION OF THE VIABILITY OF THE SNIP ITT TECHNOLOGY.
THE BRESLIN RESEARCH FOUNDATION FUNDED THE COMPLETION OF THE 3RD GENERATION PROTOTYPE OF THE CUTTING EDGE BIOTECHNOLOGY KNOWN AS SNIP ITT(SYSTEMATIC NEUROMORPHIC INTELLIGENCE PROPAGATION INFORMATION TRANSFER TECHNOLOGY). IN PHASE 1, TWO TEST ARTICLES WERE SUBMITTED TO THE NEW YORK MEDICAL COLLEGE FOR STUDIES ON CANCER CELL LINES. THE STUDIES WERE TESTED AND DEEMED HIGHLY SIGNIFICANT AND WORTHY OF ONGOING RESEARCH. A PHASE 2 STUDY LOOKED AT TELOMERE LENGTH AND TELOMERASE QUANTITATIVE EXPRESSION ALONG WITH MULTIPLE TUMOR SUPPRESSOR GENES. BOTH PHASES PROVIDED SIGNIFICANT VERIFICATION OF THE VIABILITY OF THE SNIP ITT TECHNOLOGY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Joseph Breslin President | Officer | 40 | $85,000 |
Orion Paulden Secretary | Officer | 10 | $16,830 |
Clifton Bain Director | Trustee | 10 | $7,560 |
Jody Paine Treasurer | Officer | 1 | $0 |
Stewart Breslin Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $407,253 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $407,253 |
| Total Program Service Revenue | $0 |
| Investment income | $26 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $407,279 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $119,021 |
| Compensation of current officers, directors, key employees. | $59,315 |
| Compensation to disqualified persons | $109,390 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $7,920 |
| Fees for services: Accounting | $3,672 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $9,631 |
| Advertising and promotion | $189 |
| Office expenses | $2,710 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $6,298 |
| Travel | $14,967 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $19,203 |
| Insurance | $0 |
| All other expenses | $135,586 |
| Total functional expenses | $337,910 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $115,352 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $114,469 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $229,821 |
| Accounts payable and accrued expenses | $69,995 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $31,640 |
| Other liabilities | $0 |
| Total liabilities | $101,635 |
| Net assets without donor restrictions | $128,186 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $160,290 |
| Total liabilities and net assets/fund balances | $229,821 |
Grants Recieved
Over the last fiscal year, we have identified 1 grants that Breslin Research Foundation has recieved totaling $130,000.
| Awarding Organization | Amount |
|---|---|
Fidelity Investments Charitable Gift Fund Boston, MA PURPOSE: For grant recipient's exempt purposes | $130,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Alpine Autism Center Colorado Springs, CO | $2,660,038 | $3,462,124 |
Blessed Be Hope For Three Inc Sugar Land, TX | $904,194 | $725,055 |
Rutledge Foundation Fort Worth, TX | $884,985 | $909,188 |
Breslin Research Foundation Taos, NM | $229,821 | $407,279 |
Texas Liver Foundation Houston, TX | $56,315 | $213,534 |
Vail Breast Cancer Awareness Group Edwards, CO | $0 | $0 |
Coalition For Americas Health Mckinney, TX | $74,574 | $0 |
Susan Poorman Blackie Ovarian Cancer Foundation Richmond, TX | $0 | $3 |
National Pain Advocacy Center Boulder, CO | $42,592 | $0 |
Team Uncle Joe Katy, TX | $9,727 | $0 |
Kk-125 Ovarian Cancer Research Foundation College Station, TX | $74,576 | $3,359 |
Sickle Cell Awareness Network Inc Frisco, TX | $1,195 | $0 |